The Safety and Efficacy of New-Generation BRS vs. DCB for De Novo Large Coronary Artery Lesions: A Prospective RCT

Clinical trial NCT07162792 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07162792
Sponsor: Xuzhou Third People's Hospital
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Coronary Artery Disease(CAD)de Novo Coronary Lesions

Start date: 2025-10-23
Primary completion: 2027-12-30
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.